全文获取类型
收费全文 | 305篇 |
免费 | 27篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 9篇 |
妇产科学 | 8篇 |
基础医学 | 39篇 |
口腔科学 | 8篇 |
临床医学 | 29篇 |
内科学 | 90篇 |
皮肤病学 | 7篇 |
神经病学 | 26篇 |
特种医学 | 14篇 |
外科学 | 32篇 |
综合类 | 26篇 |
预防医学 | 8篇 |
眼科学 | 1篇 |
药学 | 24篇 |
肿瘤学 | 12篇 |
出版年
2021年 | 3篇 |
2020年 | 1篇 |
2018年 | 4篇 |
2017年 | 3篇 |
2016年 | 7篇 |
2015年 | 8篇 |
2014年 | 10篇 |
2013年 | 12篇 |
2012年 | 7篇 |
2011年 | 7篇 |
2010年 | 14篇 |
2009年 | 21篇 |
2008年 | 16篇 |
2007年 | 4篇 |
2006年 | 8篇 |
2005年 | 15篇 |
2004年 | 16篇 |
2003年 | 10篇 |
2002年 | 11篇 |
2001年 | 9篇 |
2000年 | 18篇 |
1999年 | 7篇 |
1998年 | 9篇 |
1997年 | 9篇 |
1996年 | 10篇 |
1995年 | 5篇 |
1994年 | 7篇 |
1993年 | 15篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 1篇 |
1989年 | 6篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 5篇 |
1982年 | 1篇 |
1981年 | 7篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1974年 | 5篇 |
1972年 | 2篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有334条查询结果,搜索用时 15 毫秒
61.
Y Barnavon H Iwaki J A Bash F Brettschneider S Hilsenbeck E Darnell M K Wallack 《The Journal of surgical research》1988,45(6):523-530
To evaluate the feasibility and utility of vaccinia colon oncolysates (VCO) and low-dose interleukin-2 (IL-2) immunotherapy for advanced colon cancer, we have developed a murine model and tested the efficacy of combined treatment regimens. We employed intrasplenic injection of cultured colon adenocarcinomas (C-C36) in syngeneic Balb/c mice to produce experimental hepatic metastases. In the first set of experiments, animals were challenged with 5 X 10(5) tumor cells and sacrificed 14 days following tumor challenge. In the second set of experiments, animals were challenged with 2 X 10(5) tumor cells and followed for survival over the ensuing 90 days. In the first set of experiments, animals were treated prophylactically with VCO (40 micrograms, sc, 14 and 7 days prior to challenge) and/or therapeutically with IL-2 (25,000 u, Hoffmann-LaRoche rIL-2, ip BID, on Days 1-3 following challenge). In the second set of experiments, animals were treated with either the identical regimens or therapeutically with VCO (same dose, sc, 2 and 10 days following challenge) and/or IL-2 (same dose, ip BID, on Days 9-11 following challenge). Tumor burden data from sacrificed animals was in agreement with survival data and showed significant tumor burden reduction in the combined treatment group as assessed by liver weight and tumor nodule enumeration. Survival data demonstrated highly significant survival advantage for animals treated with the two biological response modifiers: VCO (P less than 0.0021), and IL-2 (P less than 0.0017). The data presented suggest a synergistic effect for these two agents.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
62.
A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates 总被引:2,自引:0,他引:2
M K Wallack K R McNally E Leftheriotis H Seigler C Balch H Wanebo A A Bartolucci J A Bash 《Cancer》1986,57(3):649-655
Vaccinia melanoma oncolysates (VMO) were tested in a Southeastern Cancer Study Group (SECSG) Phase I/II trial. Forty-eight patients with high-risk Stage I or pathologic Stage II disease were placed on study at six different dose levels and two different treatment regimens. Patients were monitored for toxicity to the VMO after each injection. Patients' sera were tested for anti-human melanoma reactivity with the Staphylococcus Protein A (SpA) assay. Toxicity was minimal at all doses tested. In only 2 of 19 patients on delayed treatment did reactivity develop in the SpA assay by 6 months. However, 13 of 23 patients on immediate treatment showed reactivity, including 8 of 8 at the two highest doses. Since the VMO appears to be safe at all of the doses tested, and because of the immunogenicity of the VMO at the higher doses as demonstrated by the SpA assay, the 2-mg dose level, for immediate treatment, was chosen for use in future trials. 相似文献
63.
64.
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO) 总被引:3,自引:0,他引:3
M K Wallack K McNally M Michaelides J Bash A Bartolucci H Siegler C Balch H Wanebo 《The American surgeon》1986,52(3):148-151
Forty-eight patients with nonrecurrent high risk Stage I and II malignant melanoma were treated with Vaccinia Melanoma Oncolysates (VMO). Six different dose levels and two different treatment regimens were tested. Thirty-two out of 48 patients completed the 12 months of therapy. Side effects were mild to moderate. Twenty-eight out of 48 patients remain free from disease with a mean survival of 19 months, while 20/48 patients have recurred with a mean time to recurrence of 6 months. 相似文献
65.
Fifty four children were studied 1-14 (mean 5.6) years after fabrications of illness had been identified. Thirty of the 54 children were living in families with their biological mothers and 24 were with other family members or in substitute families. Further fabrications were identified for 10 children who had been living with their mothers and there were 'other concerns' for a further eight children. Thirteen children residing with mother and 14 not residing with mother at follow up had a range of disorders including conduct and emotional disorders, and problems related to school, including difficulties in attention and concentration and non-attendance. Overall, 20 children (49% of those successfully followed up) had outcomes that were considered to be unacceptable. 相似文献
66.
Ferdinand Serracino-Inglott Ioannis T Virlos Nagy A Habib Robin CN Williamson Robert T Mathie 《BMC gastroenterology》2002,2(1):22-6
Background
Previous work has suggested that in the liver, adenosine preconditioning is mediated by nitric oxide. Whether the endothelial isoform of nitric oxide synthase plays a part in this mechanism has however not yet been investigated.Methods
Wistar rats were used (6 in each group) – Groups: (1) sham, (2) ischemia-reperfusion, (3) adenosine + ischemia-reperfusion, (4) endothelial isoform inhibitor + adenosine + ischemia-reperfusion.Results
Using immunohistochemistry, this study has revealed a decrease in the expression of endothelial nitric oxide synthase following hepatic ischemia-reperfusion. This was prevented by adenosine pre-treatment. When an inhibitor of endothelial nitric oxide synthase was administered prior to adenosine pre-treatment, pre-conditioning did not occur despite normal expression of endothelial nitric oxide synthase.Conclusions
These findings suggest that adenosine attenuates hepatic injury by preventing the downregulation of endothelial nitric oxide synthase that occurs during ischemia-reperfusion. 相似文献67.
J A Bash 《Transplantation proceedings》1999,31(3):1458-1459
68.
同型半胱氨酸水平,MTHFR基因突变与原发性高血压的病例对照研究 总被引:3,自引:0,他引:3
从上海一个社区中随机选取127例35~75岁的原发性高血压病人和170例正常血压者。采用聚合酶链反应-限制性片段长度多态性分析MTHFR基因多态性。使用高效液相色谱结合电化学方法检测血清中同型半胱氨酸总浓度,使用放射免疫法同时测定血甭中叶酸和B12浓度。结果:调整年龄和性别后,病例和对照组同型半胱氨酸水平分别为10.56μmol/L和10.34μmol/L,差异无显著性(P=0.63)。在未服降压 相似文献
69.
Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia 总被引:8,自引:0,他引:8
Kanagaratnam L Tomassoni G Schweikert R Pavia S Bash D Beheiry S Neibauer M Saliba W Chung M Tchou P Natale A 《Journal of the American College of Cardiology》2001,37(5):1408-1414
OBJECTIVES: To describe a normal heart left bundle branch block, inferior axis ventricular tachycardia (VT), that could not be ablated from the right or left ventricular outflow tracts. BACKGROUND: Whether these VTs are epicardial and can be identified by a specific electrocardiographic pattern is unclear. METHODS: Twelve patients with normal heart left bundle branch block, inferior axis VT and previously failed ablation were included in this study. Together with mapping in the right and left ventricular outflow tracts, we obtained percutaneous epicardial mapping in the first five patients and performed aortic sinus of Valsalva mapping in all patients. RESULTS: No adequate pace mapping was observed in the right and left ventricular outflow tracts. Earliest ventricular activation was noted in the epicardium and the aortic cusps. All patients were successfully ablated from the aortic sinuses of Valsalva (95% CI 0% to 18%). The electrocardiographic pattern associated with this VT was left bundle branch block, inferior axis and early precordial transition with Rs or R in V2 or V3. Ventricular tachycardia from the left sinus had rS pattern in lead I, and VT from the noncoronary sinus had a notched R wave in lead I. None of the patients had complications and all remained arrhythmia-free at a mean follow-up of 8 +/- 2.6 months. CONCLUSIONS: Normal heart VT with left bundle branch block, inferior axis and early precordial transition can be ablated in the majority of patients from either the left or the noncoronary aortic sinus of Valsalva. 相似文献
70.